133 related articles for article (PubMed ID: 15649143)
1. Translocation of the cell-penetrating Tat peptide across artificial bilayers and into living cells.
Curnow P; Mellor H; Stephens DJ; Lorch M; Booth PJ
Biochem Soc Symp; 2005; (72):199-209. PubMed ID: 15649143
[TBL] [Abstract][Full Text] [Related]
2. Insertion of TAT peptide and perturbation of negatively charged model phospholipid bilayer revealed by neutron diffraction.
Chen X; Sa'adedin F; Deme B; Rao P; Bradshaw J
Biochim Biophys Acta; 2013 Aug; 1828(8):1982-8. PubMed ID: 23643891
[TBL] [Abstract][Full Text] [Related]
3. Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.
Zhang X; Jin Y; Plummer MR; Pooyan S; Gunaseelan S; Sinko PJ
Mol Pharm; 2009; 6(3):836-48. PubMed ID: 19278221
[TBL] [Abstract][Full Text] [Related]
4. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.
Vivès E; Brodin P; Lebleu B
J Biol Chem; 1997 Jun; 272(25):16010-7. PubMed ID: 9188504
[TBL] [Abstract][Full Text] [Related]
5. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis.
Ziegler A; Blatter XL; Seelig A; Seelig J
Biochemistry; 2003 Aug; 42(30):9185-94. PubMed ID: 12885253
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.
Silhol M; Tyagi M; Giacca M; Lebleu B; Vivès E
Eur J Biochem; 2002 Jan; 269(2):494-501. PubMed ID: 11856307
[TBL] [Abstract][Full Text] [Related]
7. No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides.
Krämer SD; Wunderli-Allenspach H
Biochim Biophys Acta; 2003 Jan; 1609(2):161-9. PubMed ID: 12543377
[TBL] [Abstract][Full Text] [Related]
8. Cell-penetrating HIV1 TAT peptides float on model lipid bilayers.
Ciobanasu C; Harms E; Tünnemann G; Cardoso MC; Kubitscheck U
Biochemistry; 2009 Jun; 48(22):4728-37. PubMed ID: 19400584
[TBL] [Abstract][Full Text] [Related]
9. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
10. Photodamage of lipid bilayers by irradiation of a fluorescently labeled cell-penetrating peptide.
Meerovich I; Muthukrishnan N; Johnson GA; Erazo-Oliveras A; Pellois JP
Biochim Biophys Acta; 2014 Jan; 1840(1):507-15. PubMed ID: 24135456
[TBL] [Abstract][Full Text] [Related]
11. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells.
Thorén PE; Persson D; Isakson P; Goksör M; Onfelt A; Nordén B
Biochem Biophys Res Commun; 2003 Jul; 307(1):100-7. PubMed ID: 12849987
[TBL] [Abstract][Full Text] [Related]
12. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
13. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans.
Console S; Marty C; García-Echeverría C; Schwendener R; Ballmer-Hofer K
J Biol Chem; 2003 Sep; 278(37):35109-14. PubMed ID: 12837762
[TBL] [Abstract][Full Text] [Related]
14. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
15. Modulation of nuclear internalization of Tat peptides by fluorescent dyes and receptor-avid peptides.
Shen D; Liang K; Ye Y; Tetteh E; Achilefu S
FEBS Lett; 2007 May; 581(9):1793-9. PubMed ID: 17416362
[TBL] [Abstract][Full Text] [Related]
16. Translocation of a beta-peptide across cell membranes.
Umezawa N; Gelman MA; Haigis MC; Raines RT; Gellman SH
J Am Chem Soc; 2002 Jan; 124(3):368-9. PubMed ID: 11792194
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
[TBL] [Abstract][Full Text] [Related]
18. Translocation and nuclear accumulation of monomer and dimer of HIV-1 Tat basic domain in triticale mesophyll protoplasts.
Chugh A; Eudes F
Biochim Biophys Acta; 2007 Mar; 1768(3):419-26. PubMed ID: 17214959
[TBL] [Abstract][Full Text] [Related]
19. OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis.
Fretz MM; Koning GA; Mastrobattista E; Jiskoot W; Storm G
Biochim Biophys Acta; 2004 Oct; 1665(1-2):48-56. PubMed ID: 15471570
[TBL] [Abstract][Full Text] [Related]
20. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide.
Bhorade R; Weissleder R; Nakakoshi T; Moore A; Tung CH
Bioconjug Chem; 2000; 11(3):301-5. PubMed ID: 10821645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
